Important considerations before combining these medications include: Absolute contraindications : The combination should be avoided in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, during or within 14 days of MAOI use, personal/family history of MTC or MEN2, pregnancy, breastfeeding, or severe gastrointestinal disease Cardiovascular risk assessment : Phentermine increases heart rate and blood pressure, which requires careful monitoring with baseline and follow-up measurements of vital signs and possibly EKG if cardiac history exists Gastrointestinal tolerability : Tirzepatide commonly causes nausea, vomiting, and diarrhea, which may be compounded by phentermine's effects Medication interactions : Tirzepatide may reduce the effectiveness of oral contraceptives during initiation and dose escalation
Patients should only source peptides from reputable clinics and consult licensed practitioners
JAMA 294 , 557562 (2005)
Hy i su vo th gii ca hp cht hp dn ny v khm ph rt nhiu li ch ca n
Key Takeaways IV glutathione treatment puts the antioxidant in your bloodstream bypassing the digestive system, resulting in 100% bioavailability